Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study.

Gardiner SK, Demirel S, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2013 Apr;120(4):724-30. doi: 10.1016/j.ophtha.2012.09.056. Epub 2013 Jan 26.

PMID:
23357622
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study.

Gardiner SK, Demirel S, De Moraes CG, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Invest Ophthalmol Vis Sci. 2013 Feb 15;54(2):1252-9. doi: 10.1167/iovs.12-10218.

PMID:
23349433
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study.

Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2012 Sep;119(9):1826-31. doi: 10.1016/j.ophtha.2012.02.050. Epub 2012 May 16.

PMID:
22608478
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.

De Moraes CG, Demirel S, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Invest Ophthalmol Vis Sci. 2012 Apr 2;53(4):1704-9. doi: 10.1167/iovs.11-8186.

PMID:
22395889
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The rate of visual field change in the ocular hypertension treatment study.

Demirel S, De Moraes CG, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):224-7. doi: 10.1167/iovs.10-7117.

PMID:
22159015
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.

Brandt JD, Gordon MO, Gao F, Beiser JA, Miller JP, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2012 Mar;119(3):437-42. doi: 10.1016/j.ophtha.2011.03.018. Epub 2011 Jun 25.

PMID:
21705084
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.

Artes PH, Chauhan BC, Keltner JL, Cello KE, Johnson CA, Anderson DR, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2010 Dec;128(12):1528-32. doi: 10.1001/archophthalmol.2010.292.

PMID:
21149774
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The utility of the monocular trial: data from the ocular hypertension treatment study.

Bhorade AM, Wilson BS, Gordon MO, Palmberg P, Weinreb RN, Miller E, Chang RT, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2010 Nov;117(11):2047-54. doi: 10.1016/j.ophtha.2010.02.020. Epub 2010 Aug 12.

PMID:
20619460
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2010 Mar;128(3):276-87. doi: 10.1001/archophthalmol.2010.20.

PMID:
20212196
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The incidence of retinal vein occlusion in the ocular hypertension treatment study.

Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2010 Mar;117(3):484-8. doi: 10.1016/j.ophtha.2009.08.022. Epub 2010 Jan 19.

PMID:
20031222
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study.

Bhorade AM, Gordon MO, Wilson B, Weinreb RN, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2009 Apr;116(4):717-24. doi: 10.1016/j.ophtha.2008.12.036. Epub 2009 Feb 25. Erratum in: Ophthalmology. 2009 May;116(5):822. Weinrab, Robert N [corrected to Weinreb, Robert N].

PMID:
19243824
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Diabetes and glaucoma.

Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2008 May;126(5):746-7. doi: 10.1001/archopht.126.5.746-b. No abstract available.

PMID:
18474807
[PubMed - indexed for MEDLINE]
13.

Changes in central corneal thickness over time: the ocular hypertension treatment study.

Brandt JD, Gordon MO, Beiser JA, Lin SC, Alexander MY, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2008 Sep;115(9):1550-6, 1556.e1. doi: 10.1016/j.ophtha.2008.02.001. Epub 2008 Apr 18.

PMID:
18378313
[PubMed - indexed for MEDLINE]
14.

Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?

Gordon MO, Beiser JA, Kass MA; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2008 Feb;126(2):280-1. doi: 10.1001/archophthalmol.2007.35. No abstract available.

PMID:
18268230
[PubMed - indexed for MEDLINE]
15.

Visual field quality control in the Ocular Hypertension Treatment Study (OHTS).

Keltner JL, Johnson CA, Cello KE, Bandermann SE, Fan J, Levine RA, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group.

J Glaucoma. 2007 Dec;16(8):665-9.

PMID:
18091452
[PubMed - indexed for MEDLINE]
16.

Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study.

Mansberger SL, Hughes BA, Gordon MO, Spaner SD, Beiser JA, Cioffi GA, Kass MA; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2007 Apr;125(4):454-9.

PMID:
17420364
[PubMed - indexed for MEDLINE]
17.

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.

Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group, Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA.

Ophthalmology. 2007 Jan;114(1):10-9. Epub 2006 Nov 7.

PMID:
17095090
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.

Budenz DL, Anderson DR, Feuer WJ, Beiser JA, Schiffman J, Parrish RK 2nd, Piltz-Seymour JR, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2006 Dec;113(12):2137-43. Epub 2006 Sep 25.

PMID:
16996592
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.

Keltner JL, Johnson CA, Anderson DR, Levine RA, Fan J, Cello KE, Quigley HA, Budenz DL, Parrish RK, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2006 Sep;113(9):1603-12.

PMID:
16949445
[PubMed - indexed for MEDLINE]
20.

Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.

Levine RA, Demirel S, Fan J, Keltner JL, Johnson CA, Kass MA; Ocular Hypertension Treatment Study Group.

Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3896-903.

PMID:
16936102
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk